Roche’s Alzheimer’s Drug Fails In Phase III Giving Eisai/Biogen A Clear Run

Fails To Produce Significant Slowing Of Disease

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.